Succinctly, IL-37 inhibits SMC inflammation, necroptosis, and proliferation, thus converting SMC to a contractile phenotype, and also inhibits the proliferative secretory phenotype, thereby inhibiting AAA formation. The gene discussed is IL37; the disease is triple-A syndrome.